Novartis enters SMA race acquiring AveXis for US$8.7bn

05:47 EDT 11 Apr 2018 | European Biotechnology News

Original Article: Novartis enters SMA race acquiring AveXis for US$8.7bn

More From BioPortfolio on "Novartis enters SMA race acquiring AveXis for US$8.7bn"